台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效

國光生

(4142)
可現股當沖
  • 股價
    27.80
  • 漲跌
    ▲0.20
  • 漲幅
    +0.72%
  • 成交量
    432
  • 產業
    上市 生技醫療類股
  • 635人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
國光生 (4142)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/13 ~ 2024/04/27     後一日»

券商獲利排行 - 2024/04/13 ~ 2024/04/27

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.53%1,550.91,709-158.15502,1471,59728.528.129.227.8
  5.15%297.243.6253.610622612025.525.425.827.8
  2.62%148.731.5117.21382107227.12727.427.8
  5.41%147.466.181.3-60359528.627.329.227.8
  2.40%128.50128.5-188018828.5028.527.8
  6.43%127.320.5106.8-52146729.628.329.827.8
  10.59%115.6115.60039392826.529.427.8
  2.82%113.3115.4-2.1451429728.327.82927.8
  4.76%110.59.9100.68287526.726.628.627.8
  2.20%109.40.1109.3-1314217428.628.628.627.8
  3.08%107.4100.47-1311112527.927.428.327.8
  3.85%94.364.529.8-54348827.826.528.427.8
  6.13%93.856.137.632562427.326.62927.8
  4.60%89.765.424.3-24456928.227.428.827.8
  0.74%89.5146.6-57.2-28415744127.426.727.627.8
  3.78%89.512.576.9-63198228.928.42927.8
  1.37%86.588.1-1.6-11611323027.52727.827.8
  8.43%86.425.560.9-2963529.325.729.927.8
  4.52%85.815.969.9-6066628.726.32927.8
  4.90%85.84936.7-37256228.226.828.827.8
  6.09%82.554.727.820503027.126.428.227.8
  5.12%79.78.870.9-41115329.328.729.527.8
  8.53%7945.433.6-1616322927.129.927.8
  2.44%74.363.510.81211210027.226.927.527.8
  6.85%73.942.131.8-22153828.426.429.227.8
  3.84%70.532.238.3-48176528.226.728.627.8
  10.78%66.964.62.32222028.226.729.927.8
  3.07%6549.215.7-21547528.227.628.527.8
  2.08%62.3593.3-179110827.727.32827.8
  4.81%61.520.940.6-24194429.128.329.427.8
  2.97%57.818.938.961711027.427.229.127.8
  4.48%55.737.917.824452127.627.128.927.8
  0.18%55.532.323.2-2868451,13227.927.827.927.8
  4.70%54.115.338.9-29104028.827.629.127.8
  5.38%52.127.524.718361826.926.42827.8
  7.67%48.113.734.31524826.125.727.427.8
  5.15%46.73511.711332127.526.828.527.8
  3.76%45.831.514.3-15284328.327.628.827.8
  0.17%45.768.7-23-26671097627.727.627.727.8
  4.63%45.736.29.5-10253528.127.328.827.8
  3.25%43.340.42.9-7414827.827.228.227.8
  2.59%4121.719.2-29275628.227.728.527.8
  2.89%40.427.41319513227.427.12827.8
  4.54%40.216.823.5-19113128.627.42927.8
  3.84%405.434.7-2783628.928.42927.8
  5.55%39.929.510.56272126.726.127.527.8
  3.48%39.434.25.1-16254127.626.828.127.8
  9.44%39.439.400151527.826.529.127.8
  3.87%39.328.510.9-11243628.227.528.727.8
  2.86%39.321.118.229502127.527.228.227.8

券商虧損排行 - 2024/04/13 ~ 2024/04/27

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -6.67%-364.1-67.2-296.9-1723420726.428.126.127.8
  -1.72%-281.96.1-288-5514960027.327.227.327.8
  -3.17%-232.8-163.8-69-7819026927.327.826.927.8
  -6.39%-208.5-8-200.5104110629.729.728.427.8
  -6.14%-193.1-188.8-4.3-129911128.329.327.427.8
  -6.33%-177.1-171.7-5.45100952828.927.127.8
  -1.63%-164.5-47.4-117.12763588228.128.227.627.8
  -1.80%-159-39-120-16216432627.127.327.127.8
  -2.33%-136.2-104.5-31.7-2818921726.927.226.727.8
  -5.53%-127-111.7-15.21682662828.827.127.8
  -4.66%-117.9-6.1-111.8-9329526.729.726.627.8
  -5.00%-106.8-27.1-79.7-57228026.727.726.427.8
  -6.48%-99.2-64.6-34.6-28285627.328.926.627.8
  -7.01%-89.1-11.2-77.83943429.629.82727.8
  -3.04%-83.5-79.8-3.79999027.828.227.327.8
  -4.71%-83.2-73.3-9.9-11526427.628.42727.8
  -5.00%-81.9-72.5-9.45575128.729.427.927.8
  -3.50%-81.2-82.51.3486822727.526.527.8
  -5.04%-80.2-75.4-4.86575127.928.627.127.8
  -6.36%-80-79.3-0.70444527.928.927.127.8
  -8.59%-76-59.6-16.4-628342627.225.127.8
  -5.72%-73-19.5-53.53344102929.427.427.8
  -2.40%-72.7-29.8-42.9-882211027.528.727.327.8
  -1.27%-67.2-41.9-25.3-1335719027.828.327.627.8
  -4.25%-66.3-63.9-2.413574427.42826.527.8
  -6.62%-63.9-59.4-4.43343128.429.327.427.8
  -5.73%-63.2-46.1-17.114392528.32927.227.8
  -3.76%-55.1-12.6-42.438511328.728.927.927.8
  -4.03%-54.2-40.3-13.9-16334927.428.226.927.8
  -5.74%-51.6-50.5-1132312828.827.227.8
  -3.60%-48-33.9-14.1946372929.428.527.8
  -6.64%-47.4-40.3-7.1-6202627.528.626.627.8
  -3.19%-46.6-9.2-37.436511528.728.828.227.8
  -10.42%-46-4600161627.62926.227.8
  -2.34%-44.4-7.1-37.356671128.428.527.827.8
  -2.43%-44.2-8-36.25564928.328.527.627.8
  -7.16%-42.9-42.4-0.6-2192128.629.727.527.8
  -1.27%-42.7-43.10.4-635612028.128.627.827.8
  -3.95%-42.5-32.1-10.311382728.228.727.627.8
  -4.26%-42.3-20.3-2222351228.328.827.127.8
  -5.26%-42.2-18.9-23.318281028.629.127.227.8
  -5.10%-41.7-40.5-1.2-1293027.22826.627.8
  -4.69%-41.1-38.9-2.11312928.228.927.527.8
  -8.54%-40.6-17.7-22.9-1071826.428.225.727.8
  -4.73%-37.5-1.1-36.4-2643026.426.726.427.8
  -3.41%-36.8-24-12.8-21173927.628.627.227.8
  -4.36%-36.7-27.6-9.111301928.128.627.227.8
  -5.96%-36.4-11-25.4-1672326.627.826.227.8
  -3.61%-35.9-12.5-23.314342029.229.528.827.8
  -3.83%-34.7-20.7-1415321728.328.727.527.8
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章